The Sentante Robotic System – Sentante

By merging precise mechatronics, sensorics, digital data, AI and connectivity, we are building a world where life-saving vascular interventions are universally accessible, and robotics become an extension of the expert’s hands.

The company’s Sentante is a teleoperated endovascular robotic platform designed to enable remote vascular interventions using standard, off-the-shelf guidewires and catheters. It provides haptic force feedback and real-time robotic control to support precision during minimally invasive endovascular procedures, with its initial commercial version CE-marked for peripheral interventions. Additionally, Sentante’s next-generation system specifically designed for ischemic stroke treatment has received FDA Breakthrough Device Designation and has been accepted into the FDA Total Product Life Cycle (TAP) Advisory Program, supporting its continued clinical development and regulatory progression.